MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Levodopa effect on non-motor symptoms in late stage Parkinson’s disease

K. Rosqvist, P. Odin, P. Hagell, S. Iwarsson, M. Nilsson, A. Storch (Lund, Sweden)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Levodopa induced dyskinesia is preventable (15 years experience using continuous dopaminergic stimulation)

M. Lin, R. Laureno (Washington, DC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Levodopa Induced Orthostatic Hypotension in Parkinson’s Disease: A Single-Dose Response Study

K. Thiankhaw, S. Tanprawate, A. Soontornpun, A. Nudsasarn, S. Chankrachang (Chiang Mai, Thailand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Levosulpiride Induced Movement Disorder: 7 cases

D. Radhakrishnan, V. Goyal (New Delhi, India)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

Neuroimaging (Non-PD)  ·  Hall 3FG
1:45pm-3:15pm
Linking neuroplastic effects to behavioral changes after balance training in Parkinson’s disease: a study protocol of a randomized controlled trial

E. Franzén, H. Johansson, M. Freidle, U. Ekman, E. Schalling, A. Lebedev, M. Lövdén, S. Holmin, P. Svenningsson, M. Hagströmer (Huddinge, Sweden)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Liquid sinemet in the management of complex motor fluctuations in advanced Parkinson’s Disease

C. Sung, M. Danoudis, R. Iansek (Melbourne, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Long term clinical outcome after deep brain stimulation of the thalamic VIM in Holmes Tremor: A case series

J. Becktepe, S. Paschen, F. Goevert, A. Helmers, G. Deuschl (Kiel, Germany)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Long Term Response to L-dopa in Parkinson Disease

H. Gupta, N. Wachter, K. Lyons, R. Pahwa (Kansas, KS, USA)

Neuropharmacology  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 59
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley